Herbal Monograph
Sage
Salvia officinalis L.
Lamiaceae (Labiatae)
Mediterranean aromatic herb for cognitive support, menopausal symptoms, and oropharyngeal health
Overview
Plant Description
Salvia officinalis is a low-growing, woody-based, evergreen subshrub reaching 30-70 cm in height. The stems are erect, branched, quadrangular (a characteristic of the mint family), and become woody at the base with age. Young stems are covered in dense, fine, white woolly hairs. The leaves are opposite, petiolate (lower) to subsessile (upper), oblong-lanceolate to ovate, 2.5-8 cm long and 1-2.5 cm wide, with a finely crenulate margin, a wrinkled or rugose upper surface, and a prominently reticulate-veined, densely tomentose underside that gives them a characteristic silvery-grey-green appearance. The leaf texture is velvety to the touch due to abundant glandular and non-glandular trichomes. Flowers appear in late spring to early summer in whorled racemes of 5-10 flowers per whorl. The calyx is tubular-campanulate, bilabiate, and pubescent. The corolla is 2-3 cm long, typically violet-blue to lavender (occasionally pink or white in cultivated varieties), strongly bilabiate with a hooded upper lip and a three-lobed lower lip. Two stamens are present with a distinctive lever mechanism facilitating pollination. The fruit consists of four smooth, ovoid, dark brown nutlets approximately 2.5 mm in diameter. The entire plant is strongly aromatic when bruised, releasing the characteristic warm, camphoraceous, slightly peppery sage scent from its abundant essential oil glands.
Habitat
Salvia officinalis is native to the northern Mediterranean coast and thrives in rocky, calcareous, well-drained soils in sunny, warm positions at elevations from sea level to approximately 800 m. It is characteristic of garrigue and maquis shrubland communities of the Adriatic coast. The species tolerates poor, alkaline soils and is moderately drought-resistant once established, but does not tolerate waterlogged conditions. It prefers full sun to light partial shade and is hardy to USDA zones 5-9 (tolerating winter temperatures to approximately -15 degrees C when established, though young plants are less cold-hardy). In its native Dalmatian habitat, it grows alongside Rosmarinus officinalis, Thymus vulgaris, Lavandula angustifolia, and Helichrysum italicum in open, rocky limestone terrain.
Distribution
Native to the Mediterranean region, particularly the Dalmatian coast of Croatia, Montenegro, and Albania, extending through southern Europe from the Iberian Peninsula to the Balkans and Turkey. The species has been extensively cultivated and naturalized well beyond its native range, now found throughout temperate Europe, North and South America, southern Africa, and Australia. The Dalmatian coast remains the premier source of high-quality Salvia officinalis leaf and essential oil for commercial trade, prized for its optimal thujone-to-cineole ratio. Significant commercial cultivation also occurs in Albania, Turkey, Greece, Italy, France, Spain, Hungary, the United States (particularly the Pacific Northwest and Northeast), and more recently in China and India. Wild-harvested material from the Adriatic coast is generally considered pharmacologically superior to cultivated material from other regions due to the specific chemotype selected by the terroir.
Parts Used
Leaf (Salviae officinalis folium)
Preferred: Dried leaf for infusion or tincture; fresh leaf for culinary use and gargle preparations
The primary medicinal part. Pharmacopoeial monographs (European Pharmacopoeia, German Pharmacopoeia) specify the dried leaf of Salvia officinalis L. The leaf is rich in essential oil (1.0-2.8%), polyphenols (rosmarinic acid, caffeic acid derivatives), diterpenes (carnosic acid, carnosol), triterpenes (ursolic acid, oleanolic acid), and flavonoids. Both fresh and dried leaf are used therapeutically, though dried leaf is the standard pharmacopoeial form. The leaf is the basis for infusions, tinctures, fluid extracts, and standardized dry extracts used in clinical practice and clinical trials.
Essential oil (Salviae officinalis aetheroleum)
Preferred: Diluted in carrier oil for topical use; diluted in water for gargle; professional use only for internal administration
Obtained by steam distillation of the fresh or partially dried leaves and flowering tops. Chemically complex, dominated by monoterpenes including alpha-thujone (18-43%), beta-thujone (3-8.5%), camphor (4.5-24.5%), 1,8-cineole (5.5-13%), alpha-humulene, alpha-pinene, camphene, limonene, and linalool, along with sesquiterpenes. The European Pharmacopoeia provides specific composition ranges for pharmacopoeial-grade sage essential oil. Used externally as a gargle (diluted), in liniments, and in aromatherapy. Internal use of the essential oil requires extreme caution due to thujone content and is generally reserved for professional practice.
Aerial parts (Salviae officinalis herba)
Preferred: Dried herb for infusion or decoction
The whole herb including leaves, stems, and flowers is occasionally used in traditional preparations, particularly in folk medicine decoctions and poultices. The stems and flowers contribute additional volatile compounds but at lower concentrations than the leaves alone. Not the standard pharmacopoeial form but referenced in some traditional texts.
Key Constituents
Monoterpenoids (Essential oil components)
The essential oil fraction is primarily responsible for sage's antimicrobial, carminative, diaphoretic, and spasmolytic actions. The volatile terpenoids provide direct antiseptic activity in the oral cavity and upper respiratory tract when used as gargles or inhalations. The thujone content, while contributing to pharmacological activity at low doses, is the primary safety-limiting factor for internal use. Camphor and 1,8-cineole contribute warming, counterirritant, and expectorant properties relevant to traditional topical and respiratory applications.
Phenolic acids and polyphenols
The phenolic acid fraction, particularly rosmarinic acid, is the primary driver of sage's potent antioxidant activity and contributes significantly to its anti-inflammatory, antiviral, and neuroprotective effects. Rosmarinic acid is water-soluble and well-extracted in infusions and aqueous-alcoholic preparations, making it the dominant active constituent in sage tea. The phenolic fraction works synergistically with the essential oil and diterpene fractions to produce sage's overall therapeutic profile.
Diterpenes (Abietane-type)
The abietane diterpenes, particularly carnosic acid and carnosol, provide powerful lipophilic antioxidant protection distinct from the water-soluble rosmarinic acid fraction. They are especially relevant to sage's neuroprotective and potential anticarcinogenic properties. These compounds are preferentially extracted in alcoholic preparations (tinctures, fluid extracts) and lipophilic solvents, supporting the traditional use of sage tincture for conditions requiring antioxidant and anti-inflammatory support.
Triterpenes
The high concentration of ursolic acid in sage leaf is pharmacologically significant, contributing to the herb's anti-inflammatory, hepatoprotective, and metabolic-modulating effects. Triterpenes are not extracted in aqueous preparations (tea) and require alcoholic or lipophilic solvents, which has implications for preparation selection based on therapeutic intent.
Flavonoids
The flavonoid fraction contributes to sage's antioxidant, anti-inflammatory, and mild nervine activity. Apigenin and hispidulin are particularly notable for their interactions with GABA-A receptors, which may contribute to sage's traditional use as a nervine and may partially counterbalance the GABA-antagonist effects of thujone in whole-plant preparations. Flavonoids are moderately extracted in both aqueous and hydroalcoholic preparations.
Condensed tannins and other polyphenols
The tannin fraction is directly responsible for sage's pronounced astringent action. Tannins precipitate proteins on mucosal surfaces, creating a protective barrier that reduces inflammation, decreases excessive secretions (including sweat gland secretions, partially explaining the antihidrotic effect), and inhibits bacterial adhesion. This is clinically relevant for oral/pharyngeal inflammation (gargling) and excessive perspiration.
Herbal Actions
Kills or inhibits the growth of microorganisms
Broad-spectrum antimicrobial activity demonstrated against gram-positive bacteria (including MRSA), gram-negative bacteria, Candida species, and several viruses. Activity attributed to the essential oil (thujone, camphor, 1,8-cineole), phenolic diterpenes (carnosic acid, carnosol), and rosmarinic acid. The Commission E monograph recognizes sage's antiseptic properties, and the herb is widely used as a gargle for oropharyngeal infections. In vitro studies confirm activity against Streptococcus mutans, Staphylococcus aureus, Escherichia coli, Candida albicans, and Herpes simplex virus.
[1, 6, 18]Tightens and tones tissue, reduces secretions
Strong astringent action due to 3-8% condensed tannins. Sage is one of the most astringent herbs in the European materia medica. The tannins precipitate mucosal proteins, tightening tissues, reducing excessive secretions, and creating a protective barrier against microbial invasion. This action underpins sage's well-established use as a gargle for sore throat, pharyngitis, and stomatitis, and its traditional use for excessive sweating (the astringent effect on sweat gland ducts contributes to the antihidrotic action).
[1, 23, 24]Relieves intestinal gas and bloating
Relaxes smooth muscle spasm in the gastrointestinal tract and promotes the expulsion of intestinal gas. The essential oil components (1,8-cineole, camphor, borneol) act directly on GI smooth muscle and have been shown to inhibit acetylcholine-induced contractions in isolated guinea pig ileum. The Commission E monograph approves sage for dyspeptic complaints. The carminative action is enhanced by sage's bitter constituents, which stimulate digestive secretions.
[1, 2, 23]Reduces inflammation
Multi-mechanism anti-inflammatory activity through inhibition of COX-2, 5-LOX, NF-kB, and complement activation. Rosmarinic acid, carnosic acid, carnosol, ursolic acid, and luteolin all contribute. The anti-inflammatory action is relevant to sage's use in oropharyngeal inflammation (Commission E, EMA), digestive inflammation, and topical applications for skin conditions. Clinical evidence from gargle studies confirms reduction of pharyngeal inflammation.
[1, 3, 21]Relieves smooth muscle spasm
Relaxes smooth muscle in the gastrointestinal and respiratory tracts. Essential oil components, particularly 1,8-cineole and camphor, demonstrate spasmolytic activity on isolated smooth muscle preparations. Contributes to sage's carminative action and its traditional use for intestinal cramping and colic.
[2, 25]Enhances cognitive function, memory, and mental performance
Cholinesterase-inhibiting activity demonstrated for both the essential oil and ethanolic extracts. Multiple RCTs have demonstrated improved cognitive function, memory, and attention in both healthy volunteers and Alzheimer's disease patients. The mechanism involves inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) by monoterpenoids (1,8-cineole, alpha-pinene, camphor) and rosmarinic acid. Carnosic acid provides additional neuroprotection through Nrf2 activation. This action distinguishes sage from most other culinary herbs.
[8, 9, 10]Prevents or slows oxidative damage to cells
Exceptionally potent antioxidant activity through multiple mechanisms: rosmarinic acid (radical scavenging, metal chelation), carnosic acid and carnosol (lipid peroxidation inhibition, Nrf2 activation), flavonoids (radical scavenging), and ursolic acid (indirect antioxidant gene upregulation). Sage extracts consistently demonstrate superior antioxidant capacity in ORAC, DPPH, and FRAP assays compared to most other culinary and medicinal herbs. The food industry uses sage extracts (often labeled as 'rosemary extracts' under E392) as natural antioxidant preservatives.
[19, 24]Stimulates digestive secretions via bitter taste receptors
Mild bitter tonic action stimulating digestive secretions including saliva, gastric acid, bile, and pancreatic enzymes via bitter taste receptor (T2R) activation. The bitter quality is moderate compared to dedicated bitter herbs like Gentiana lutea or Artemisia absinthium, but contributes meaningfully to sage's efficacy in dyspeptic complaints. This action synergizes with the carminative and antispasmodic effects.
[1, 23]Promotes perspiration
Paradoxically, sage has a dual relationship with perspiration. As a warm diaphoretic tea taken hot at the onset of fever, it can promote sweating (traditional use in feverish colds). However, taken at room temperature or in sustained doses, sage is distinctly antihidrotic (reduces excessive sweating), an action validated by the Bommer et al. (2011) clinical trial on menopausal hot flashes. This antihidrotic effect is attributed to a combination of astringent tannins acting on sweat gland ducts and central modulation of the thermoregulatory center.
[7, 23, 24]Supports and calms the nervous system
Mild nervine tonic and relaxant. Sage has traditionally been used for nervous exhaustion, anxiety, and cognitive decline. The anxiolytic flavonoids apigenin and hispidulin (GABA-A receptor modulators), combined with rosmarinic acid's anti-inflammatory neuroprotective effects and the cholinesterase-inhibiting essential oil, contribute to a nervine profile. Human trials report improved mood, reduced anxiety, and increased alertness following sage administration.
[9, 10, 23]Stimulates or increases menstrual flow
Traditional reputation as a mild emmenagogue promoting menstrual flow. The essential oil has demonstrated weak estrogenic activity in some in vitro assays, and sage has a long history of use for amenorrhea and scanty menses in European folk medicine. This action, combined with the thujone content, is the basis for the Class 2b pregnancy restriction. The estrogenic effect may also partially explain sage's efficacy in menopausal symptoms.
[23, 25, 35]Promotes wound healing
Topical wound-healing activity supported by the antimicrobial, anti-inflammatory, astringent, and antioxidant properties acting in concert. Traditional use in poultices and washes for wounds, ulcers, and skin conditions. The tannins and rosmarinic acid promote tissue repair while the essential oil prevents infection.
[23, 26]Therapeutic Indications
Digestive System
Dyspepsia (functional indigestion)
Commission E approved indication. Sage's combined carminative, antispasmodic, bitter tonic, and antimicrobial actions address multiple mechanisms of functional dyspepsia. The essential oil relaxes GI smooth muscle, the bitter constituents stimulate digestive secretions, and the carminative action relieves bloating and gas. Used as an infusion (tea) before or after meals. ESCOP and the British Herbal Pharmacopoeia also recognize this indication.
[1, 2, 5]Gastritis and gastric inflammation
Traditional use of sage tea for inflammation of the gastric mucosa, supported by the anti-inflammatory (rosmarinic acid, carnosic acid) and mucosal-protective (tannin) properties. Animal studies confirm gastroprotective effects of sage extracts against ethanol-induced gastric damage.
[23, 24]Respiratory System
Pharyngitis and sore throat
Commission E approved for inflammation of the mucous membranes of the mouth and pharynx. EMA well-established use for symptomatic treatment of inflammations in the mouth and throat. A randomized, double-blind clinical trial (Hubbert et al., 2006) demonstrated that a sage/echinacea spray was as effective as a chlorhexidine/lidocaine spray for acute sore throat. Used as a gargle or spray. The astringent tannins reduce mucosal swelling, the essential oil provides local antiseptic action, and rosmarinic acid and other polyphenols reduce inflammation.
[1, 3, 11]Stomatitis and gingivitis
Well-established use as a mouth rinse for inflammation of the oral mucosa (EMA). The combined astringent, antimicrobial, and anti-inflammatory actions make sage one of the most effective herbal treatments for oral inflammations. Used as a strong infusion for mouth rinsing or as a tincture diluted in water.
[1, 2, 3]Upper respiratory tract infections (supportive treatment)
Traditional use of hot sage tea at the onset of colds and fevers to promote sweating and support the body's febrile response. The expectorant action of 1,8-cineole, combined with the antimicrobial essential oil and immune-supportive properties, make sage a useful adjunct in acute upper respiratory infections. Often combined with elderflower (Sambucus nigra) and peppermint (Mentha x piperita) in traditional cold formulas.
[23, 24, 26]Nervous System
Mild to moderate Alzheimer's disease
A landmark 4-month randomized, double-blind, placebo-controlled trial (Akhondzadeh et al., 2003) demonstrated that S. officinalis extract (60 drops/day of a 1:1 tincture) significantly improved cognitive function (ADAS-cog score) and reduced agitation in patients with mild to moderate Alzheimer's disease compared to placebo. The mechanism involves inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), the same target as conventional drugs donepezil and rivastigmine. A systematic review (Miroddi et al., 2014) confirmed evidence supporting sage for cognitive enhancement in dementia, though more large-scale trials are needed.
[8]Age-related cognitive decline and memory impairment
Multiple RCTs in healthy young and older adults demonstrate that single doses and short courses of S. officinalis and S. lavandulifolia improve memory (word recall, speed of memory), attention, and mood. Kennedy et al. (2006) showed dose-dependent improvement in memory and attention in healthy young adults. Scholey et al. (2008) confirmed cognitive-enhancing effects including improved secondary memory performance and increased alertness/calmness. The cholinesterase-inhibiting terpenoids and the neuroprotective polyphenols (rosmarinic acid, carnosic acid) are the proposed active principles.
[9, 10]Anxiety (mild)
Improved mood and reduced anxiety have been reported as secondary outcomes in cognitive trials (Kennedy et al., Scholey et al.). The anxiolytic flavonoids apigenin and hispidulin may contribute. Traditional nervine indication. Insufficient evidence from dedicated anxiety trials to establish this as a primary indication.
[9, 10]Endocrine System
Menopausal hot flashes and night sweats
A pivotal open-label clinical trial (Bommer et al., 2011) in 71 menopausal women demonstrated that a standardized sage tablet (Swissmedic-registered preparation, containing dried ethanolic sage leaf extract) reduced the frequency and intensity of hot flashes by 50% within 4 weeks and 64% within 8 weeks, with significant reductions in the severity of very severe flashes. The EMA lists traditional use of sage for menopausal symptoms including excessive sweating. The mechanism is multifactorial: antihidrotic activity (tannin-mediated astringent effect on sweat glands), possible weak phytoestrogenic activity (in vitro data), and central thermoregulatory modulation.
[3, 7, 20]Excessive perspiration (hyperhidrosis)
Commission E approved indication. Sage has a long and well-documented tradition of use for excessive sweating of various etiologies, including menopausal night sweats, tuberculosis-associated sweats, and idiopathic hyperhidrosis. The antihidrotic action is one of sage's most distinctive therapeutic properties. Onset of action occurs within 2 hours of a single dose, with maximal effect after several days of regular use. Both the aqueous extract (tea) and alcoholic preparations are effective.
[1, 2, 7]Reproductive System
Menstrual irregularity (amenorrhea, oligomenorrhea)
Long-standing traditional use as a mild emmenagogue to promote menstrual flow and regulate the cycle. Referenced in the Eclectic and traditional European literature. The mechanism may involve weak estrogenic activity demonstrated in some in vitro studies. Clinical evidence is limited to traditional use reports.
[23, 25, 27]Lactation suppression (weaning support)
Traditional use to reduce excessive milk production or to support the weaning process. Sage tea (2-3 cups daily) is commonly recommended in European herbal traditions for this purpose. The antihidrotic (anti-secretory) action and possible anti-galactagogue effects of the essential oil are proposed mechanisms. Limited clinical evidence but widely used empirically with reported efficacy by lactation consultants and midwives. Contraindicated during active breastfeeding when lactation is desired.
[23, 24, 34]Skin / Integumentary
Wounds and skin ulcers (topical)
Traditional topical application as a wash, compress, or poultice for slow-healing wounds, skin ulcers, and abrasions. The combined antimicrobial, astringent, anti-inflammatory, and vulnerary actions support wound healing and infection prevention. Used as a strong infusion or diluted tincture applied to the affected area.
[23, 26]Immune System
Oropharyngeal infections (adjunct therapy)
The potent antimicrobial activity of sage against common oral and throat pathogens (Streptococcus, Staphylococcus, Candida), combined with its anti-inflammatory and astringent properties, makes it an effective adjunct for treating oropharyngeal infections. The Hubbert et al. (2006) clinical trial demonstrated efficacy comparable to a conventional antiseptic spray.
[1, 11, 18]Cardiovascular System
Hyperlipidemia (adjunct)
A small RCT (Kianbakht et al., 2011) in hyperlipidemic type 2 diabetic patients showed that sage leaf extract (500 mg three times daily for 2 months) significantly decreased total cholesterol, triglycerides, and LDL while increasing HDL compared to placebo. Ursolic acid and carnosic acid are proposed lipid-modulating constituents. Requires confirmation in larger trials.
[13]Hyperglycemia (type 2 diabetes, adjunct)
Several small clinical studies suggest sage extract may improve glycemic control in type 2 diabetes. Kianbakht et al. (2011) demonstrated reduced fasting glucose and HbA1c. Proposed mechanisms include inhibition of alpha-glucosidase by phenolic compounds and enhancement of insulin sensitivity by ursolic acid. Sage tea has traditional use for diabetes management in Mediterranean folk medicine. Not a replacement for conventional diabetes management.
[13]Energetics
Temperature
warm
Moisture
dry
Taste
Tissue States
damp/stagnation, damp/relaxation, hot/excitation (oropharyngeal inflammation)
Sage is a classically warm and drying herb in the Western energetic tradition, making it particularly well-suited for conditions characterized by dampness, excess secretions, and lax tissue tone. The warming quality is attributed to the camphor and thujone-rich essential oil, while the drying quality derives from the high tannin content and astringent action. The pungent and aromatic taste reflects the volatile oil fraction, while the bitter taste indicates the diterpene and flavonoid components. In Ayurvedic terms, sage would be considered to reduce Kapha and balance Vata in moderate doses, though it may aggravate Pitta if used excessively (warming nature). In traditional Unani (Greco-Islamic) medicine, sage is classified as hot in the second degree and dry in the first degree (some authors say dry in the second degree), consistent with Western energetic assessment. The warming and drying energetics inform clinical application: sage is best indicated for cold, damp constitutions and conditions with excessive secretions (sweating, diarrhea, excessive salivation, leucorrhea), poor digestion with bloating, and conditions of tissue laxity. It is relatively contraindicated in dry, hot presentations and should be used cautiously in individuals with a dry, depleted constitution.
Traditional Uses
European (Mediterranean) Folk Medicine
- Gargle for sore throat, tonsillitis, and mouth ulcers (one of the oldest and most consistent uses)
- Digestive tea for bloating, gas, and indigestion after heavy meals
- Reduction of excessive perspiration, particularly menopausal night sweats
- Fever management (hot sage tea to promote sweating during colds)
- Wound washing and antiseptic poultice for cuts, abrasions, and slow-healing ulcers
- Women's remedy for menstrual irregularity, to suppress milk production during weaning, and for menopausal symptoms
- General tonic for debility, convalescence, and nervous exhaustion
- Fumigation of sickrooms (burning dried sage) to purify air and ward off contagion
- External wash for itchy skin, insect bites, and skin inflammations
- Hair rinse to darken grey hair and improve scalp condition
"The Latin name Salvia derives from 'salvare' (to save or heal), reflecting the high esteem in which this herb was held throughout European medical history. The medieval School of Salerno posed the famous question: 'Cur moriatur homo cui Salvia crescit in horto?' (Why should a man die whilst sage grows in his garden?). This proverb, recorded in the Regimen Sanitatis Salernitanum (c. 12th-13th century), encapsulates the extraordinary reputation sage held as a panacea in medieval European medicine."
Eclectic American Medicine
- Sore throat gargle and mouth wash (primary indication)
- Night sweats, particularly in tuberculosis and debilitating fevers
- Nervous headache and nervous trembling
- Chronic gastric catarrh and atonic dyspepsia
- To check excessive secretions: salivation, perspiration, diarrhea, leucorrhea, and lactation
- Intermittent fever (as an adjunct to quinine)
- Chronic bronchitis with profuse mucous discharge
"Felter and Lloyd wrote in King's American Dispensatory (1898): 'Sage is a feeble tonic and astringent, used chiefly in domestic practice. A warm infusion is diaphoretic and expectorant, and in large doses is emetic. A cold infusion checks excessive secretions, as in night-sweats, salivation, etc. It has been found useful in spermatorrhea and excessive mucous discharges.' They further note: 'Used locally in the form of a gargle for sore throat, ulcerated throat, and relaxed uvula, and as a wash for sore mouth, and bleeding or spongy gums.'"
Islamic / Unani (Greco-Islamic) Medicine
- Treatment of sore throat and oral infections (known as 'Maryamiyah' or 'Maramiyah')
- Digestive complaints and loss of appetite
- Strengthening of memory and treatment of forgetfulness
- Women's complaints including menstrual irregularity and uterine coldness
- Headache and migraine
- Joint pain and stiffness
- As an antidote to poisons (traditional belief)
"Ibn Sina (Avicenna) in Al-Qanun fi al-Tibb (The Canon of Medicine, c. 1025 CE) classified sage as hot in the second degree and dry in the first degree, recommending it for paralysis, palsy, and nervous trembling, and as a gargle for throat affections. He noted its properties for strengthening the intellect and memory, a use remarkably consistent with modern cholinesterase-inhibiting findings."
Traditional European Herbalism (Renaissance)
- Memory and brain tonic ('Sage for the brain, strengthens the memory')
- Gargle for quinsy (peritonsillar abscess) and sore throat
- Digestive aid and liver cleanser
- Plague remedy and general disinfectant
- Women's fertility herb and menstrual regulator
- Tooth cleaning and gum strengthening
- Treatment of palsy and trembling of the limbs
- Hair darkening and scalp treatment
"John Gerard in his Herball (1597) wrote: 'Sage is singularly good for the head and brain, it quickeneth the senses and memory, strengtheneth the sinews, restoreth health to those that have the palsie, and taketh away shaking or trembling of the members.' Nicholas Culpeper in The English Physician (1653) added: 'Sage is of excellent use to help the memory, warming and quickening the senses...the juice of Sage drank with vinegar hath been of good use in the time of the plague at all times.'"
Native American Medicine
- Note: Salvia officinalis is a European species not traditionally used by Native American peoples. The 'sage' used in Native American traditions is primarily Artemisia spp. (white sage = Salvia apiana, and sagebrush = Artemisia tridentata), which are botanically and medicinally distinct. S. apiana (White Sage) is used ceremonially for smudging and spiritual cleansing. This entry is included to clarify a common confusion.
"The ceremonial and medicinal 'sage' of Native American traditions should not be confused with Salvia officinalis. Salvia apiana (White Sage) and Artemisia tridentata (Big Sagebrush) are the species used in smudging ceremonies and traditional healing practices. Salvia officinalis was introduced to the Americas by European colonists and is not part of pre-contact indigenous pharmacopoeias."
[33]
Modern Research
Menopausal hot flashes and night sweats
A pivotal Swiss open-label clinical trial demonstrated that a standardized sage tablet significantly reduced the frequency and severity of menopausal hot flashes over 8 weeks, providing the strongest clinical evidence for sage's antihidrotic and menopausal symptom-relieving effects.
Findings: Bommer et al. (2011) conducted an open-label, multicenter trial in 71 menopausal women experiencing at least 5 hot flashes per day. Participants received a once-daily tablet containing 280 mg of dried ethanolic sage leaf extract (Ze 450, drug-to-extract ratio 1:17-21, extraction solvent ethanol 50% v/v). The mean total number of hot flashes decreased by 50% within 4 weeks and 64% within 8 weeks (p < 0.001 for both time points vs. baseline). Notably, the frequency of very severe hot flashes decreased by 79% and severe hot flashes by 62% at 8 weeks. Mild hot flashes increased slightly, suggesting a shift from severe to mild episodes rather than complete suppression. Patient-reported quality of life (Menopause Rating Scale) improved significantly across all domains (somatic, psychological, urogenital). The treatment was well-tolerated with no serious adverse events. The study confirmed the traditional European use of sage for excessive perspiration and menopausal complaints.
Limitations: Open-label design without placebo control, limiting ability to distinguish treatment effects from placebo response and natural fluctuation. Relatively short duration (8 weeks). Single standardized extract (Ze 450) tested, limiting generalizability to other sage preparations. Predominantly Swiss/German population. No comparison with conventional HRT. Despite these limitations, the effect size was substantial and clinically meaningful, and the results are consistent with traditional use over centuries.
[7]
Cognitive function in Alzheimer's disease
A randomized, double-blind, placebo-controlled trial demonstrated that Salvia officinalis extract significantly improved cognitive function and reduced agitation in patients with mild to moderate Alzheimer's disease over 4 months.
Findings: Akhondzadeh et al. (2003) randomized 42 patients with mild to moderate Alzheimer's disease (NINCDS-ADRDA criteria, CDR 1-2) to receive either S. officinalis extract (60 drops/day of a 1:1 hydroalcoholic tincture, equivalent to approximately 2.5 mL) or placebo for 16 weeks. The sage group showed significantly better outcomes on the ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale) at 4-month follow-up compared to placebo (p < 0.001). Sage also significantly reduced agitation measured by the CMAI (Cohen-Mansfield Agitation Inventory) compared to placebo (p < 0.01). The improvements were clinically meaningful, with the sage group showing a 3.5-point advantage on the ADAS-cog versus placebo. There were no significant differences in adverse effects between groups. The study provided the first placebo-controlled clinical evidence that sage possesses genuine anti-dementia activity, consistent with in vitro cholinesterase inhibition data.
Limitations: Small sample size (n=42). Single-center study conducted in Iran. 16-week duration may not reflect long-term efficacy or safety. Non-standardized tincture preparation (1:1 tincture described but no standardization to specific constituents). Specific thujone content not reported, raising questions about applicability to other preparations. No direct comparison with cholinesterase inhibitor drugs. Replication by independent groups is needed.
[8]
Acute cognitive enhancement in healthy adults
Multiple randomized, placebo-controlled crossover trials have demonstrated that single doses of Salvia officinalis and S. lavandulifolia extracts acutely enhance memory, attention, and mood in healthy young and older adults.
Findings: Kennedy et al. (2006) conducted a randomized, placebo-controlled, double-blind, balanced crossover study in 30 healthy young adults testing dried sage leaf (300 mg and 600 mg) on cognitive performance using the CDR computerized cognitive assessment battery. The 300 mg dose significantly improved memory (quality of memory factor) and the 600 mg dose improved mood ratings (increased alertness, calmness, and contentedness) compared to placebo. Scholey et al. (2008) conducted a similar crossover trial testing a standardized sage extract (containing 10 mg rosmarinic acid per capsule; 167 mg, 333 mg, 666 mg doses) in 20 healthy young adults. The 333 mg dose significantly improved secondary memory performance (immediate and delayed word recall) and the highest dose reduced anxiety. An earlier trial by Tildesley et al. (2003) with S. lavandulifolia essential oil (25 and 50 microliters) showed improved word recall, speed of memory, and mood in 24 healthy volunteers. These consistent findings across multiple independent trials, preparations, and research groups provide convergent evidence for sage's acute cognitive-enhancing effects.
Limitations: Small sample sizes (20-30 per trial). Acute single-dose designs do not address long-term efficacy. Different sage species and preparations used across trials (dried herb, standardized extract, essential oil) make direct comparison difficult. Primarily conducted in young, healthy populations; relevance to age-related cognitive decline requires further study. Mechanism not fully elucidated (likely involves cholinesterase inhibition, anti-inflammatory, and antioxidant mechanisms).
Sore throat treatment (sage/echinacea spray)
A randomized, double-blind clinical trial demonstrated that a sage-echinacea combination spray was non-inferior to a conventional chlorhexidine-lidocaine spray for the treatment of acute sore throat.
Findings: Hubbert et al. (2006) conducted a randomized, double-blind, active-controlled non-inferiority trial in 154 patients with acute sore throat. Participants were randomized to receive either a sage-echinacea spray (S. officinalis tincture + E. purpurea root tincture, 2 sprays up to 10 times daily for 5 days) or a chlorhexidine-lidocaine spray (standard pharmaceutical comparator, same dosing regimen). The primary endpoint was reduction in sore throat symptoms assessed by a visual analogue scale (VAS) over 5 days. The sage-echinacea spray showed non-inferiority to the chlorhexidine-lidocaine spray in reducing sore throat symptoms. Response rates after 3 days (at least 50% symptom reduction) were 63.8% for sage-echinacea vs. 57.8% for chlorhexidine-lidocaine (not statistically different). Both treatments were well-tolerated. This trial supports the traditional use of sage gargle for pharyngitis and demonstrates that an herbal preparation can match a standard antiseptic/local anesthetic combination.
Limitations: Active-controlled design without a placebo arm, so the absolute efficacy of either treatment cannot be confirmed. Combination product (sage + echinacea) prevents attribution of effects to sage alone. 5-day follow-up may be too short to capture complete resolution. Self-reported symptom scores rather than objective clinical measures. Funded by the manufacturer of the herbal spray.
[11]
Cholinesterase inhibition (in vitro)
Multiple in vitro studies have demonstrated that Salvia officinalis extracts and essential oil components inhibit both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), providing a mechanistic basis for the observed cognitive-enhancing effects in clinical trials.
Findings: Perry et al. (1996, 2000) were among the first to systematically screen Salvia species for AChE inhibition, finding that S. officinalis and S. lavandulifolia essential oils exhibited significant dose-dependent AChE inhibition in vitro (IC50 values in the range of 0.003-0.06 mg/mL for various fractions). The monoterpenoids 1,8-cineole, alpha-pinene, and camphor were identified as active inhibitors. Savelev et al. (2003) further characterized the synergistic interactions between these components, finding that the whole essential oil was more potent than individual components, suggesting synergistic AChE inhibition. Rosmarinic acid also inhibits BuChE. Orhan et al. (2008) confirmed AChE and BuChE inhibition by various S. officinalis extracts (methanolic, aqueous, hexane) with the methanolic extract showing the strongest activity. These findings provide a clear pharmacological rationale for the clinical cognitive-enhancing effects observed in the Akhondzadeh et al. (2003), Kennedy et al. (2006), and Scholey et al. (2008) trials.
Limitations: In vitro activity does not necessarily translate to in vivo efficacy due to absorption, distribution, and metabolism factors. IC50 values vary widely depending on the assay method, substrate concentration, and extract preparation. The contribution of cholinesterase inhibition relative to other mechanisms (antioxidant, anti-inflammatory) in clinical cognitive effects is not fully defined. Central nervous system penetration of active terpenoids needs further characterization.
Antimicrobial activity
Extensive in vitro studies confirm broad-spectrum antimicrobial activity of Salvia officinalis essential oil and extracts against clinically relevant bacteria, fungi, and viruses.
Findings: Bozin et al. (2007) demonstrated that S. officinalis essential oil exhibited significant antibacterial activity against gram-positive bacteria including Staphylococcus aureus (including MRSA strains), Bacillus subtilis, and Enterococcus faecalis, and moderate activity against gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium. The essential oil also showed strong antifungal activity against Candida albicans, Aspergillus niger, and dermatophytes. Longe (2005) and multiple other studies confirm antiviral activity against Herpes simplex virus types 1 and 2, attributed primarily to rosmarinic acid and other polyphenols. Delamare et al. (2007) showed that the antimicrobial activity of sage essential oil correlated with thujone and camphor content. The activity is generally stronger against gram-positive than gram-negative organisms, consistent with the lipophilic nature of the active terpenoids.
Limitations: In vitro antimicrobial activity may not translate to clinically relevant effects at achievable tissue concentrations. MIC values vary considerably between studies depending on methodology. Many studies used essential oil or concentrated extracts at concentrations that may not be achievable with standard oral doses. Synergistic or antagonistic interactions between components are not always assessed.
Antioxidant activity
Sage extracts demonstrate exceptionally potent antioxidant activity in multiple assay systems, attributed to rosmarinic acid, carnosic acid, carnosol, and flavonoids acting through complementary mechanisms.
Findings: Lu and Foo (2002) comprehensively characterized the antioxidant phenolic constituents of S. officinalis, identifying rosmarinic acid, carnosic acid, carnosol, rosmanol, and multiple flavonoid glycosides as the principal antioxidant compounds. Sage extracts showed very high ORAC values (oxygen radical absorbance capacity) and potent inhibition of LDL oxidation in vitro. Carnosic acid and carnosol are among the most potent natural lipophilic antioxidants known, with activity comparable to synthetic antioxidants BHT and BHA. The European food industry has authorized sage and rosemary extracts (E392) as natural antioxidant food additives based on this evidence. Lopresti (2017) reviewed the evidence comprehensively, confirming that sage's antioxidant activity operates through both direct radical scavenging and indirect upregulation of endogenous antioxidant defenses (Nrf2/ARE pathway activation by carnosic acid).
Limitations: In vitro antioxidant activity is not always predictive of in vivo antioxidant status improvement. Bioavailability of lipophilic antioxidants (carnosic acid, carnosol) from oral dosing may be limited. Clinical studies measuring plasma antioxidant capacity after sage administration are limited.
[19]
Estrogenic activity and menopausal mechanisms
In vitro studies have identified weak estrogenic activity in sage extracts, providing a partial mechanistic explanation for the herb's traditional use in menopausal symptoms alongside its antihidrotic effects.
Findings: Rahte et al. (2013) investigated the estrogenic properties of S. officinalis using estrogen receptor binding assays, reporter gene assays, and cell proliferation assays. The methanolic extract demonstrated weak but significant estrogenic activity, primarily mediated through estrogen receptor beta (ER-beta). Several flavonoid and diterpenoid compounds were identified as contributors to the estrogenic effect, including genkwanin and apigenin. The estrogenic potency was considerably weaker than 17-beta-estradiol (approximately 1,000-10,000 times weaker) but is consistent with a phytoestrogenic contribution to menopausal symptom relief at the doses used in clinical practice. This weak estrogenic activity, combined with the antihidrotic effect (tannin-mediated) and possible central thermoregulatory modulation, provides a multi-target mechanistic explanation for sage's clinical efficacy in reducing hot flashes.
Limitations: Weak in vitro estrogenic activity does not confirm clinically relevant estrogenic effects in vivo. The estrogenic potency may be too low to meaningfully contribute to menopausal symptom relief at standard doses. The study tested methanolic extracts; activity of aqueous extracts (as in sage tea) may differ. No clinical study has yet demonstrated measurable changes in estrogen levels or estrogen-dependent biomarkers after sage administration.
[20]
Glycemic and lipid effects in type 2 diabetes
A small randomized trial in type 2 diabetic patients with hyperlipidemia demonstrated improvements in glucose and lipid parameters after 2 months of sage leaf extract supplementation.
Findings: Kianbakht et al. (2011) conducted a randomized, double-blind, placebo-controlled trial in 80 type 2 diabetic patients with hyperlipidemia. Participants received either sage leaf extract (500 mg capsules three times daily, equivalent to 1500 mg/day of dried ethanolic extract) or placebo for 2 months while continuing their standard diabetic medications. The sage group showed significant reductions compared to placebo in fasting blood glucose (-14%), HbA1c (-significant reduction), total cholesterol (-16%), triglycerides (-18%), and LDL cholesterol (-20%), along with a significant increase in HDL cholesterol (+20%). No significant hepatic or renal adverse effects were observed. These results support the ethnobotanical use of sage tea for diabetes management in Mediterranean folk medicine.
Limitations: Small sample size (n=80). Single center in Iran. Short duration (2 months). High doses used (1500 mg/day of extract). No long-term safety data at this dose (thujone accumulation concerns). No assessment of sage-drug interactions with concurrent diabetic medications. Results need replication in larger, multi-center trials before clinical recommendations can be made.
[13]
Systematic review of sage for cognitive and neurological conditions
A systematic review of clinical and preclinical evidence confirmed that Salvia species demonstrate significant cognitive-enhancing and neuroprotective effects through multiple mechanisms.
Findings: Miroddi et al. (2014) conducted a systematic review of human clinical trials investigating Salvia species for cognitive enhancement and neurological conditions. The review identified the Akhondzadeh et al. (2003) Alzheimer's trial, multiple cognitive enhancement trials in healthy volunteers, and preclinical mechanistic studies. The authors concluded that there is 'promising evidence' supporting the use of sage for cognitive improvement in both healthy individuals and those with dementia. Mechanisms identified included cholinesterase inhibition, antioxidant neuroprotection, anti-inflammatory effects, and modulation of cholinergic receptor activity. Lopresti (2017) published a broader narrative review confirming these findings and expanding the analysis to include anti-inflammatory and metabolic mechanisms.
Limitations: Limited number of included clinical trials (most small sample sizes). Heterogeneity in sage species, preparations, doses, and outcome measures across studies. Publication bias possible. Primarily narrative synthesis rather than quantitative meta-analysis due to heterogeneity.
[]
Anti-inflammatory mechanisms
Preclinical studies have elucidated multiple anti-inflammatory mechanisms of sage constituents including inhibition of COX-2, NF-kB, and pro-inflammatory cytokines.
Findings: Baricevic et al. (2001) demonstrated significant anti-inflammatory activity of S. officinalis extracts in animal models (carrageenan-induced paw edema in rats), with the methanolic extract showing activity comparable to indomethacin at 100 mg/kg. Ursolic acid was identified as a major contributor. Subsequent studies have shown that rosmarinic acid inhibits complement C3 convertase, LOX, and COX-2; carnosol inhibits NF-kB nuclear translocation and reduces TNF-alpha, IL-1beta, and IL-6 production; and ursolic acid inhibits both the COX-2 and LOX pathways. These complementary mechanisms acting on multiple inflammatory pathways explain the robust anti-inflammatory activity observed in both traditional use and the clinical sore throat trial.
Limitations: Most data from animal models and in vitro studies. The specific contribution of individual constituents versus whole-extract synergy is not fully characterized. Doses used in animal studies may not be directly translatable to human clinical doses.
[21]
Preparations & Dosage
Infusion (Tea)
Strength: 1.5-4 g dried leaf per 250 mL boiling water
Place 1-2 teaspoons (1.5-4 g) of dried sage leaf in a cup (250 mL). Pour freshly boiled water over the herb. Cover immediately to prevent loss of volatile oils and steep for 10-15 minutes. Strain and drink. For gargling: prepare a stronger infusion using 2.5-5 g per cup, allow to cool to a comfortable temperature, and gargle for 30-60 seconds, then spit out. May be used for gargling up to several times daily.
1.5-4 g dried leaf per cup, 2-3 cups daily (Commission E); up to 6 g/day as infusion (ESCOP)
2-3 times daily for internal use; up to 5-6 times daily for gargling
For internal use: up to 2 weeks continuously, then take a 1-week break due to thujone content. For gargling: use for the duration of acute symptoms (typically 5-10 days). Longer-term use at culinary doses (1 cup daily) is generally acceptable.
Not recommended for children under 12 due to thujone content. For children over 12, use half adult dose for short periods only. Diluted sage tea gargle may be used cautiously in children over 6 for sore throat.
The infusion is the most traditional and widely recommended preparation for sage, providing good extraction of water-soluble polyphenols (rosmarinic acid), tannins, and some volatile components, while delivering a relatively lower dose of thujone than concentrated preparations. Covering during steeping is essential to retain the volatile essential oil fraction. The infusion is appropriate for digestive complaints, menopausal symptoms, and as a gargle for oropharyngeal inflammation. For excessive perspiration, drink the infusion at room temperature (not hot, as hot tea may promote rather than reduce sweating).
Tincture
Strength: 1:5 in 45% ethanol (tincture) or 1:1 in 45-70% ethanol (fluid extract)
Macerate dried sage leaf in ethanol-water solvent for 2-4 weeks with regular agitation. Strain and press. Alternatively, use a commercial tincture prepared to pharmacopoeial standards. Dose by drops or milliliters diluted in a small amount of water. For the Akhondzadeh et al. Alzheimer's trial, a 1:1 tincture was used at 60 drops (approximately 2.5 mL) per day.
2-6 mL daily of a 1:5 tincture (45-60% ethanol); 1-3 mL daily of a 1:1 fluid extract. Typical single dose: 1-2 mL of 1:5 tincture, 2-3 times daily.
2-3 times daily
Up to 2-4 weeks continuously, then take a 1-week break. The Akhondzadeh Alzheimer's trial used 16 weeks of continuous treatment under medical supervision.
Not recommended for children under 12. Children 12-16: half adult dose for short-term use only.
The tincture/fluid extract provides a broader constituent profile than the infusion, extracting both water-soluble (rosmarinic acid, tannins, flavonoids) and lipophilic (carnosic acid, carnosol, ursolic acid, essential oil components) constituents. This preparation is generally preferred when cognitive enhancement, neuroprotection, or systemic anti-inflammatory effects are the therapeutic goal. Higher thujone delivery per dose compared to infusion necessitates attention to duration limits. The 1:1 tincture used in the Akhondzadeh Alzheimer's trial represents a concentrated preparation; 1:5 tinctures are more commonly used in routine practice.
Capsule / Powder
Strength: 280-500 mg dried ethanolic extract (DER typically 1:17-21 for standardized products)
Take standardized sage extract capsules as directed. The Bommer et al. (2011) menopausal study used a once-daily tablet containing 280 mg of dried ethanolic sage leaf extract (Ze 450). The Kianbakht et al. (2011) diabetes study used 500 mg capsules three times daily. Swallow whole with water, with or after meals.
280-500 mg of dried sage leaf extract, 1-3 times daily depending on the product and indication. For menopausal symptoms: 280 mg once daily (Ze 450 type). For metabolic conditions: 500 mg three times daily (in clinical trial setting).
1-3 times daily depending on product and indication
Up to 8-12 weeks in clinical trial settings. Longer-term use should be supervised by a healthcare practitioner.
Not recommended for children under 18 in capsule/extract form.
Capsules and standardized extracts offer controlled dosing and reproducibility, advantages over infusions and non-standardized tinctures. The Ze 450 preparation used in the Bommer menopausal trial is standardized but the specific marker compound and assay method are proprietary. Sage extract capsules are widely available as dietary supplements. Thujone content of capsule products is variable and not always disclosed, which is a safety consideration for long-term use.
Essential Oil
Strength: Pure essential oil (100%); dilute to 1-2.5% for topical application
For external use: dilute 2-5 drops of sage essential oil in 10 mL of carrier oil (e.g., sweet almond, jojoba) for topical application or massage. For gargling: add 2-3 drops to a glass of warm water, stir well, gargle, and spit out (do not swallow). For inhalation: add 3-5 drops to a bowl of hot water or a diffuser. Internal use of the essential oil should only be undertaken under the guidance of a qualified practitioner due to thujone toxicity risk.
External: 2-5 drops diluted in carrier oil per application. Gargle: 2-3 drops in 200 mL warm water. Internal (professional use only): 1-3 drops (approximately 0.05-0.15 mL) in a suitable vehicle, 1-3 times daily.
External: 2-3 times daily. Gargle: up to 5 times daily for acute sore throat. Internal: as prescribed by practitioner.
External: for the duration of symptoms. Internal: maximum 1-2 weeks under supervision.
Not recommended for children under 12. External use only in children 6-12, at half the adult dilution.
CAUTION: Salvia officinalis essential oil contains 20-50% thujone (alpha + beta), which is a potent neurotoxin at high doses, capable of causing seizures, vomiting, and kidney damage. Internal use of the essential oil must be distinguished from use of the whole herb or aqueous/hydroalcoholic preparations, which deliver much lower thujone doses. The essential oil is approximately 50-100 times more concentrated in thujone than an equivalent weight of dried herb. Internal use of the undiluted essential oil is dangerous and must never be undertaken without professional guidance. For aromatherapy applications, sage essential oil can be diffused for respiratory support and cognitive stimulation. The essential oil is approved in the European Pharmacopoeia with specified ranges for key constituents.
Glycerite
Strength: 1:5 in 60% glycerin
Macerate dried sage leaf in a mixture of glycerin and water (typically 60:40 glycerin:water) for 4-6 weeks with regular agitation, or prepare by a warm extraction method. Strain and press. The glycerite is alcohol-free and suitable for patients who avoid ethanol.
3-5 mL, 2-3 times daily
2-3 times daily
Up to 2-4 weeks
Children 6-12: 1-2 mL, 2-3 times daily for short-term use (sore throat gargle or digestive complaints). Consult a practitioner.
The glycerite provides an alcohol-free alternative suitable for children, pregnant women (short-term, low-dose use for sore throat gargling only), and those avoiding alcohol. Glycerites are generally less potent extractors of lipophilic constituents compared to tinctures, meaning lower carnosic acid and ursolic acid extraction but adequate extraction of water-soluble polyphenols and tannins. The sweet taste may improve compliance. Less commonly available commercially than tinctures.
[23]
Salve / Ointment
Strength: 1:5 herb-to-oil ratio, or 1-2% essential oil in salve base
Infuse dried sage leaf (1 part by weight) in a fixed oil (olive oil or sweet almond oil, 5 parts) by gentle warming (60-70 degrees C) for 2-4 hours. Strain, return to gentle heat, and melt in beeswax (approximately 15-20% by weight of the infused oil) to achieve desired consistency. Pour into containers while warm and allow to set. Alternatively, add sage essential oil (1-2% by weight) to a prepared salve base.
Apply a thin layer to the affected area 2-3 times daily.
2-3 times daily
For the duration of symptoms; reassess if no improvement within 7-10 days
For children over 6: apply to affected area as for adults. Not for use near the face in young children.
Topical sage salve or ointment preparations are used for minor wounds, insect bites, skin inflammations, and joint/muscle aches. The antimicrobial, anti-inflammatory, and vulnerary properties of sage are locally active when applied topically. An oromucosal application is also described in some pharmacopeias for gum massage in gingivitis.
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
Therapeutic doses of sage are contraindicated in pregnancy due to the thujone content (potential emmenagogue/abortifacient effect), demonstrated uterotonic activity of the essential oil in vitro, and the AHPA Class 2b classification ('not to be used during pregnancy'). The essential oil is particularly dangerous. Culinary amounts of sage used in normal food preparation are considered safe in pregnancy and are not restricted. The distinction between culinary use and therapeutic dosing is critical.
Thujone is a GABA-A receptor antagonist and has demonstrated pro-convulsant activity in animal studies at high doses. Patients with epilepsy or a history of seizures should avoid concentrated sage preparations (essential oil, high-dose extracts) and use only mild preparations (tea) with caution. The risk is primarily associated with the essential oil and is dose-dependent. Standard sage tea at recommended doses is unlikely to pose significant seizure risk in most patients, but caution is warranted.
Due to the weak estrogenic activity demonstrated in vitro (Rahte et al., 2013), high-dose or prolonged use of sage extracts should be avoided in patients with estrogen-receptor-positive breast cancer, endometriosis, uterine fibroids, or other estrogen-dependent conditions. The clinical significance of sage's weak phytoestrogenic activity is uncertain, but precaution is appropriate. Culinary amounts are not restricted.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Anticonvulsant medications (Anticonvulsants (phenobarbital, carbamazepine, valproic acid, phenytoin)) | moderate | Thujone is a GABA-A receptor antagonist that could theoretically reduce the seizure threshold and antagonize the effects of GABAergic anticonvulsant drugs. This interaction is primarily a concern with concentrated sage preparations (essential oil, high-dose extracts) rather than standard tea. |
| Hypoglycemic agents and insulin (Antidiabetic medications (metformin, sulfonylureas, insulin)) | moderate | Sage extracts have demonstrated hypoglycemic effects in clinical trials (Kianbakht et al., 2011), likely through alpha-glucosidase inhibition and enhanced insulin sensitivity. Concurrent use with conventional hypoglycemic agents could produce additive blood glucose-lowering effects. |
| Sedative and CNS depressant medications (Benzodiazepines, barbiturates, Z-drugs, opioid analgesics) | minor | Paradoxical interaction: the apigenin and hispidulin in sage have mild GABA-A receptor positive allosteric modulating activity (sedative), while thujone has GABA-A antagonist activity (stimulant). At standard doses, the net effect is unlikely to significantly alter sedative drug efficacy, but individual variation is possible. |
| Cholinesterase inhibitors (Anti-Alzheimer's drugs (donepezil, rivastigmine, galantamine)) | moderate | Sage extracts and essential oil components inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Concurrent use with pharmaceutical cholinesterase inhibitors could produce additive cholinergic effects. |
| Hormone replacement therapy (HRT) and oral contraceptives (Estrogen and progestogen preparations) | theoretical | Weak phytoestrogenic activity of sage (Rahte et al., 2013) could theoretically produce additive estrogenic effects or interfere with hormonal balance. The clinical significance is uncertain given the very low estrogenic potency relative to pharmaceutical estrogens. |
| Anticoagulant and antiplatelet medications (Warfarin, heparin, aspirin, clopidogrel) | theoretical | Sage contains small amounts of vitamin K (from green leaf tissue) and has demonstrated mild antiplatelet activity in some in vitro studies. Rosmarinic acid has shown anticoagulant properties in animal models. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
possibly unsafe
PREGNANCY: Therapeutic doses of sage (tincture, extract, strong tea for medicinal purposes) are classified as possibly unsafe during pregnancy due to the thujone content, which has emmenagogue and potentially abortifacient effects, and demonstrated uterotonic activity of the essential oil. The AHPA Class 2b designation specifically restricts use during pregnancy. However, normal culinary use of sage as a food seasoning is considered safe and is not restricted. The key distinction is between occasional culinary amounts (a pinch in cooking) and deliberate therapeutic dosing (multiple cups of strong tea daily, tinctures, or extracts). LACTATION: Sage is traditionally used to REDUCE breast milk production (to assist with weaning). Therefore, breastfeeding mothers who wish to maintain milk supply should avoid therapeutic doses of sage. This is not a toxicity concern but a pharmacological effect that would be counterproductive during active breastfeeding. Women intentionally weaning may use sage tea (2-3 cups daily) for this purpose. The essential oil should not be used during lactation.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council / Integrative Medicine Communications (1998) : 331-332 . ISBN: 978-0965555517
- [2] European Scientific Cooperative on Phytotherapy (ESCOP). ESCOP Monographs: Salviae officinalis folium (Sage leaf). ESCOP Monographs, 2nd Edition (2003) . ISBN: 978-1901964073
- [3] European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Salvia officinalis L., folium. EMA/HMPC/277152/2015 (2016)
- [4] World Health Organization. WHO Monographs on Selected Medicinal Plants: Folium Salviae. WHO Monographs on Selected Medicinal Plants, Volume 4 (2009) . ISBN: 978-9241547055
- [5] British Herbal Medicine Association. British Herbal Pharmacopoeia: Salvia officinalis. British Herbal Pharmacopoeia, 4th Edition (1996) . ISBN: 978-0903032094
- [6] Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine: Expanded Commission E Monographs. American Botanical Council / Integrative Medicine Communications (2000) : 330-338 . ISBN: 978-0967077222
Clinical Studies
- [7] Bommer S, Klein P, Suter A. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes. Advances in Therapy (2011) ; 28(6) : 490-500 . DOI: 10.1007/s12325-011-0027-z . PMID: 21630133
- [8] Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics (2003) ; 28(1) : 53-59 . DOI: 10.1046/j.1365-2710.2003.00463.x . PMID: 12605619
- [9] Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology (2006) ; 31(4) : 845-852 . DOI: 10.1038/sj.npp.1300907 . PMID: 16205785
- [10] Scholey AB, Tildesley NTJ, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (2008) ; 198(1) : 127-139 . DOI: 10.1007/s00213-008-1101-3 . PMID: 18350281
- [11] Hubbert M, Sievers H, Lehnfeld R, Kehrl W. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. European Journal of Medical Research (2006) ; 11(1) : 20-26 . PMID: 16504956
- [12] Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Savelev S, Wesnes KA, Scholey AB. Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacology, Biochemistry and Behavior (2003) ; 75(3) : 669-674 . DOI: 10.1016/S0091-3057(03)00122-9 . PMID: 12895685
- [13] Kianbakht S, Abasi B, Perez M, Dabaghian FH. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial. Phytotherapy Research (2011) ; 25(12) : 1849-1853 . DOI: 10.1002/ptr.3528 . PMID: 21506190
- [14] Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. Journal of Pharmacy and Pharmacology (1996) ; 48(12) : 1231-1238 . DOI: 10.1111/j.2042-7158.1996.tb03922.x . PMID: 9004183
- [15] Perry NSL, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis-Balchin M, Hoult JRS, Evans P, Jenner P, Milligan S, Perry EK. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. Journal of Pharmacy and Pharmacology (2001) ; 53(10) : 1347-1356 . DOI: 10.1211/0022357011777846 . PMID: 11697542
- [16] Savelev S, Okello E, Perry NSL, Wilkins RM, Perry EK. Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil. Pharmacology, Biochemistry and Behavior (2003) ; 75(3) : 661-668 . DOI: 10.1016/S0091-3057(03)00125-4 . PMID: 12895684
- [17] Orhan I, Kartal M, Naz Q, Ejaz A, Yilmaz G, Kan Y, Konuklugil B, Sener B, Choudhary MI. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chemistry (2007) ; 103(4) : 1247-1254 . DOI: 10.1016/j.foodchem.2006.10.030
- [18] Bozin B, Mimica-Dukic N, Samojlik I, Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. Journal of Agricultural and Food Chemistry (2007) ; 55(19) : 7879-7885 . DOI: 10.1021/jf0715323 . PMID: 17708648
- [19] Lu Y, Foo LY. Polyphenolics of Salvia - a review. Phytochemistry (2002) ; 59(2) : 117-140 . DOI: 10.1016/S0031-9422(01)00415-0 . PMID: 11809447
- [20] Rahte S, Evans R, Geis PJ, Simmonds MSJ, Sherwood RA. Estrogenic activity of extracts and isolated compounds from Salvia officinalis. Planta Medica (2013) ; 79(18) : 1732-1740 . DOI: 10.1055/s-0033-1351100 . PMID: 24222343
- [21] Baricevic D, Sosa S, Della Loggia R, Tubaro A, Simonovska B, Krasna A, Zupancic A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. Journal of Ethnopharmacology (2001) ; 75(2-3) : 125-132 . DOI: 10.1016/S0378-8741(00)00396-2 . PMID: 11297842
- [22] Delamare APL, Moschen-Pistorello IT, Artico L, Atti-Serafini L, Echeverrigaray S. Antibacterial activity of the essential oils of Salvia officinalis L. and Salvia triloba L. cultivated in South Brazil. Food Chemistry (2007) ; 100(2) : 603-608 . DOI: 10.1016/j.foodchem.2005.09.078
Traditional Texts
- [23] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press (2003) : 585-587 . ISBN: 978-0892817498
- [24] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine, 2nd Edition. Churchill Livingstone / Elsevier (2013) : 876-888 . ISBN: 978-0443069925
- [25] Mills S, Bone K. The Essential Guide to Herbal Safety. Churchill Livingstone / Elsevier (2005) : 540-543 . ISBN: 978-0443071713
- [26] Grieve M. A Modern Herbal: Sage (Salvia officinalis). Jonathan Cape / Harcourt Brace (originally 1931; Dover reprint 1971) (1931) . ISBN: 978-0486227993
- [27] Felter HW, Lloyd JU. King's American Dispensatory: Salvia. Ohio Valley Company (1898)
- [28] Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy: Salvia. Eclectic Medical Publications (1919)
- [29] Gerard J. The Herball or Generall Historie of Plantes. John Norton (London) (1597)
- [30] Culpeper N. The English Physician (Culpeper's Complete Herbal). Peter Cole (London) (1653)
- [31] Ibn Sina (Avicenna). Al-Qanun fi al-Tibb (The Canon of Medicine). Original c. 1025 CE; numerous translations (1025)
- [32] Said HM. Hamdard Pharmacopoeia of Eastern Medicine. Hamdard Academy / Sri Satguru Publications (1970)
- [33] Moerman DE. Native American Ethnobotany. Timber Press (1998) . ISBN: 978-0881924534
- [34] Romm A. Botanical Medicine for Women's Health. Churchill Livingstone / Elsevier (2010) . ISBN: 978-0443072772
- [35] Brinker F. Herbal Contraindications and Drug Interactions: Plus Herbal Adjuncts with Medicines, 4th Edition. Eclectic Medical Publications (2010) . ISBN: 978-1888483147
- [36] Tisserand R, Young R. Essential Oil Safety: A Guide for Health Care Professionals, 2nd Edition. Churchill Livingstone / Elsevier (2014) . ISBN: 978-0443062414
Pharmacopeias & Reviews
- [37] European Pharmacopoeia Monograph: Sage Leaf (Salviae officinalis folium) and Sage Oil (Salviae officinalis aetheroleum). European Pharmacopoeia, 10th Edition (2020)
- [38] United States Pharmacopeia Dietary Supplement Monograph: Sage. United States Pharmacopeia - National Formulary (USP-NF) (2020)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.